Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Foreword

Satoshi Shuto1

  • 1Faculty of Pharmaceutical Sciences, Hokkaido University.

Chemical & Pharmaceutical Bulletin
|February 2, 2018
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Resolvin E1 and Resolvin E2 suppress cyclooxygenase-2 expression through ubiquitin-proteasome-mediated degradation in human macrophage-like U937 cells.

Prostaglandins & other lipid mediators·2026
Same author

Design and Synthesis of Cyclopropane Congeners of Resolvin E2 with Azidopropoxy Chain toward a Chemical Tool for Probing the Anti-inflammatory Activity.

The Journal of organic chemistry·2025
Same author

Highly <i>Z-</i>Selective Julia-Kocienski Olefination Using <i>N</i>-Sulfonylimines and Its Mechanistic Insights from DFT Calculations.

Organic letters·2025
Same author

Identification of BAY61-3606 Derivatives With Improved Activity in Splicing Modulation That Induces Inclusion of Cassette Exons Similar to the Splicing Factor 3B Subunit 1 Mutation.

Chemical biology & drug design·2024
Same author

Development of Conformationally Restricted Negamycin Derivatives for Potent Readthrough Activity.

ACS medicinal chemistry letters·2023
Same author

Individual resolvin E family members work distinctly and in a coordinated manner in the resolution of inflammation.

Prostaglandins & other lipid mediators·2023